Feasibility of Valve-in-Valve Procedure for Degenerated St. Jude Medical Trifecta Bioprosthesis.

The Journal of Heart Valve Disease, 2015 - europepmc.org
The valve-in-valve (ViV) procedure is an option for patients with symptomatic structural
degeneration of a bioprosthesis and excessive reoperative risk. The risk of coronary …
被引用次数：7 相关文章

Feasibility of Valve-in-Valve Procedure for Degenerated St. Jude Medical Trifecta (TM) Bioprosthesis

JP Verhoye, M Harmouche, RB Soulami… - Journal of Heart Valve …, 2015 - hal.science
The valve-in-valve (ViV) procedure is an option for patients with symptomatic structural
degeneration of a bioprosthesis and excessive reoperative risk. The risk of coronary …

Feasibility of Valve-in-Valve Procedure for Degenerated St. Jude Medical Trifecta (TM) Bioprosthesis

JP Verhoye, M Harmouche… - Journal of Heart …, 2015 - univ-rennes.hal.science
The valve-in-valve (ViV) procedure is an option for patients with symptomatic structural
degeneration of a bioprosthesis and excessive reoperative risk. The risk of coronary …

Feasibility of Valve-in-Valve Procedure for Degenerated St. Jude Medical Trifecta (TM) Bioprosthesis

JP Verhoye, M Harmouche, RB Soulami… - Journal of Heart …, 2015 - inria.hal.science
The valve-in-valve (ViV) procedure is an option for patients with symptomatic structural
degeneration of a bioprosthesis and excessive reoperative risk. The risk of coronary …

Feasibility of Valve-in-Valve Procedure for Degenerated St. Jude Medical Trifecta Bioprosthesis

J Verhoye, M Harmouche… - The Journal of …, 2015 - pubmed.ncbi.nlm.nih.gov
The valve-in-valve (ViV) procedure is an option for patients with symptomatic structural
degeneration of a bioprosthesis and excessive reoperative risk. The risk of coronary …